Literature DB >> 10761364

Cognitive decline in patients with Cushing's syndrome.

H Forget1, A Lacroix, M Somma, H Cohen.   

Abstract

Chronic exposure to elevated glucocorticoid levels in Cushing's syndrome (CS), is associated with deficits in cognitive function and in emotion. The hippocampus plays a crucial role in the behavioral manifestations of the syndrome as it is richest in glucocorticoid receptors and is thus particularly vulnerable to glucocorticoid excess. The wide distribution of glucocorticoid receptors throughout the cerebral cortex, however, suggests that several cognitive functions can also be affected by the dysregulation of glucocorticoids. In this study, we investigated how an excess of glucocorticoid hormones affects cognitive processes. Nineteen patients with chronic hypercortisolemia due to CS were compared to healthy controls matched for age, sex, education, and occupation in tests of processing of visual and spatial information, memory, reasoning and concept formation, language and verbal functions, and attention. Multivariate and univariate analyses revealed overall differences in tests of treatment of visual and spatial information, reasoning and concept formation as well as in verbal and language performance, with poorer performance from CS patients. Differences were also observed in nonverbal aspects of memory and in attention tasks. The results suggest that chronic exposure to elevated levels of cortisol is associated with deficits in several areas of cognition, particularly those involving processing of selective attention and visual components. This study also shows that hormones play an important role in the modulation of cognitive function and that their influence on cerebral structure and function merits closer scrutiny.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761364     DOI: 10.1017/s1355617700611037

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  41 in total

1.  Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys.

Authors:  D M Lyons; J M Lopez; C Yang; A F Schatzberg
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Increased cortisol levels in cognitively challenging situations are beneficial in young but not older subjects.

Authors:  Juraj Kukolja; Christiane M Thiel; Oliver T Wolf; Gereon R Fink
Journal:  Psychopharmacology (Berl)       Date:  2008-08-14       Impact factor: 4.530

4.  Computerized Analysis of Brain MRI Parameter Dynamics in Young Patients With Cushing Syndrome-A Case-Control Study.

Authors:  Amit Tirosh; Harish RaviPrakash; Georgios Z Papadakis; Christina Tatsi; Elena Belyavskaya; Lyssikatos Charalampos; Maya B Lodish; Ulas Bagci; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

5.  Systemic and Local Corticosteroid Use Is Associated with Reduced Executive Cognition, and Mood and Anxiety Disorders.

Authors:  Mesut Savas; Christiaan H Vinkers; Judith G M Rosmalen; Catharina A Hartman; Vincent L Wester; Erica L T van den Akker; Anand M Iyer; Bruce S McEwen; Elisabeth F C van Rossum
Journal:  Neuroendocrinology       Date:  2019-06-21       Impact factor: 4.914

6.  Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers.

Authors:  F C Hsu; M J Garside; A E Massey; R H McAllister-Williams
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

7.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

Review 8.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Increasing parity is associated with cumulative effects on memory.

Authors:  Laura M Glynn
Journal:  J Womens Health (Larchmt)       Date:  2012-10       Impact factor: 2.681

10.  Cortisol Supplement Combined with Psychotherapy and Citalopram Improves Depression Outcomes in Patients with Hypocortisolism after Traumatic Brain Injury.

Authors:  Lanlan Luo; Yan Chai; Rongcai Jiang; Xin Chen; Tao Yan
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.